about
Platinum-based chemotherapy plus cetuximab in head and neck cancer.Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial.First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy: a subgroup analysis of data from the FLEX phase 3 study.Prognostic factors in patients with advanced non-small cell lung cancer: data from the phase III FLEX study.International, randomized, placebo-controlled, double-blind phase III study of motesanib plus carboplatin/paclitaxel in patients with advanced nonsquamous non-small-cell lung cancer: MONET1.Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Randomized Clinical Trial.Motesanib plus carboplatin/paclitaxel in patients with advanced squamous non-small-cell lung cancer: results from the randomized controlled MONET1 study.Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS).An open-label, multicenter, randomized phase Ib/II study of eribulin mesylate administered in combination with pemetrexed versus pemetrexed alone as second-line therapy in patients with advanced nonsquamous non-small-cell lung cancer.
P50
Q33381094-3F749317-04FF-4A62-AE7D-14454C275024Q33401021-05C8C9EC-FE85-4CB2-A4EF-CDD591109F0AQ33775197-64A19CEE-2888-446D-811B-74B45F1ACDF2Q34231171-C16BE77E-5210-44E4-A315-2B5B7334E357Q34285538-772EF529-FDD5-4B82-8DE7-F450D564BCE9Q38383854-9D6AE3C3-60CF-4E54-9B19-977B210D0129Q44696915-BDDBFDB4-7550-45F4-8698-337FEE24DF6BQ46027726-7B43ACDE-710E-41BC-A25E-2898AEEA4448Q48048391-057FDE77-C453-4751-A1B3-BBE59F9FE817Q53675802-CA9871EB-1F6B-4249-977C-388E0BFB7AD9
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ihor Vynnychenko
@ast
Ihor Vynnychenko
@en
Ihor Vynnychenko
@es
Ihor Vynnychenko
@nl
Ihor Vynnychenko
@sl
type
label
Ihor Vynnychenko
@ast
Ihor Vynnychenko
@en
Ihor Vynnychenko
@es
Ihor Vynnychenko
@nl
Ihor Vynnychenko
@sl
prefLabel
Ihor Vynnychenko
@ast
Ihor Vynnychenko
@en
Ihor Vynnychenko
@es
Ihor Vynnychenko
@nl
Ihor Vynnychenko
@sl
P1053
E-1684-2012
P106
P1153
24781268000
P21
P31
P3829
P496
0000-0002-2339-6509
P569
2000-01-01T00:00:00Z